Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Lundbeck initiates clinical trial in immunology for Lu AG22515 in Thyroid Eye Disease

H. Lundbeck A/S (Lundbeck) today announced taking one further step in developing treatments for indications in the neuroimmunology and neuroinflammatory space with the initiation of the first clinical trial of its CD40L blocker, Lu AG22515, in patients.Lundbeck’s proof-of-concept (PoC) trial will evaluate the efficacy, safety, and tolerability of Lu AG22515 as a potential treatment for Thyroid Eye Disease, an autoimmune disease causing a debilitating, disfiguring, and potentially blinding periocular condition. “We are excited to initiate our first project within neuroimmunology with this

Stora Enso prepares to sell parts of its forest assets in Sweden (Inside information)

STORA ENSO OYJ INSIDE INFORMATION 3 October 2024 at 10:00 EESTStora Enso is preparing to sell approximately 12% of its total forest assets of 1.4 million hectares in Sweden. Stora Enso has therefore initiated steps to implement a new legal structure for its Swedish forest assets to facilitate the potential sale. A potential transaction would be subject to agreeing terms and conditions with investors, including a long-term wood supply and forest management agreement. A sale would reduce debt and further strengthen Stora Enso’s balance sheet, confirming the financial value of the Company’s

BioStock: Cereno Scientific discusses phase IIa results for CS1

The trial was made with the company’s lead candidate, CS1, in the rare cardiovascular disease Pulmonary Arterial Hypertension. See Sten R Sörensen, CEO, announce the results and their impact on Cereno Scientific.See the interview at biostock.se:https://www.biostock.se/en/2024/10/cereno-scientific-discusses-phase-iia-results-for-cs1/This is a press release from BioStock - Connecting Innovation & Capital.

BioStock has published an article and interview with CEO Sten R. Sörensen on the positive topline results from Cereno Scientific’s Phase IIa trial on CS1 in PAH

Cereno Scientific (Nasdaq First North: CRNO B), a pioneering biotech developing innovative treatments for rare and common cardiovascular disease, today announced that BioStock has published an article and executive interview on the positive topline results from the Company’s Phase IIa trial on CS1 in rare disease Pulmonary Arterial Hypertension (PAH).In the article and interview, Cereno’s CEO Sten R. Sörensen comments on the results of the Phase IIa study in PAH as well as the importance of these new insights for the company and ultimately for patients suffering from PAH.   Read the full

BioStock: Cereno’s phase IIa results positive, clear path forward

Recently, Cereno Scientific announced positive topline results from the phase IIa trial of CS1 in pulmonary arterial hypertension. The results demonstrate that the candidate is safe, well tolerated, and has a positive impact on clinically relevant parameters. The phase IIa clinical trial data, together with preclinical information, are consistent with reversing pathological remodeling, which is in line with the development goals for CS1.Read the article about Cereno Scientific at biostock.se:  https://www.biostock.se/en/2024/10/cerenos-phase-iia-results-looks-promising 

Curasight A/S rights issue heavily oversubscribed

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, RUSSIA, BELARUS OR ANY OTHER JURISDICTION WHERE THIS PRESS RELEASE IS DISTRIBUTABLE WOULD BE ILLEGAL OR REQUIRE ADDITIONAL ACTIONS THAN SUCH ACTIONS RESULTING FROM DANISH LAW. SEE THE “IMPORTANT INFORMATION” SECTION AT THE END OF THIS PRESS RELEASE. Copenhagen, Denmark, 3 October 2024 – The subscription period in Curasight A/S (“Curasight” or the “Company” – TICKER: CURAS) preferential rights

Valmet to supply an OptiConcept M board making line to Anhui Linping Circular Development in China

Valmet Oyj press release, October 3, 2024, at 9:30 a.m. EESTValmet is to supply an OptiConcept M  board making line with automation and services to Anhui Linping Circular Development in China. The new board line PM 8 will produce recycled liner grades. The start-up is scheduled for the end of 2025. The order is included in Valmet's orders received of the third quarter 2024. The value of the order will not be disclosed, but such a board making line is typically worth between EUR 40 million and EUR 60

Nordnet: Monthly statistics September

In September, Nordnet’s customers made 3,948,100 trades in listed financial instruments, which corresponds to 188,000 trades per day. The number of new customers in September amounted to 37,600 and the number of new customers in 2024 is 187,200. The total number of customers at the end of September was 2,050,000. Net savings for September was SEK 3.8 billion and the total net savings during 2024 is SEK 53.7 billion. The savings capital was SEK 989 billion and lending amounted to SEK 31.1 billion at the end of September.September August Change  September Change

TF Bank AB (publ): Invitation to the presentation of the Interim report for January – September 2024

TF Bank AB will publish its interim report for the period January – September 2024 on Tuesday 15 October 2024 at 07.00 CET. We welcome media, institutional investors, analysts and other interested parties to participate in a conference call at 08.15 CET. Agenda (CET) 07.00 – Interim report published 08.15 – Conference call with CEO Joakim Jansson and CFO Mikael Meomuttel who will present the Interim report. It will be possible to ask questions after the presentation. To follow the conference call online go to www.tfbankgroup.com. To participate in the conference call, please

Compressor distributor in the Netherlands has become part of Atlas Copco Group

Nacka, Sweden, October 3, 2024: Perslucht Wilda B.V. (“Perslucht Wilda”), a compressor distributor headquartered in Woudenberg, Netherlands, has become part of Atlas Copco Group.The acquisition of Perslucht Wilda has been finalized. The company provides portable air compressors, generators, light towers and small electric compressors and associated services and has 9 employees. The purchase price is not disclosed The company has become part of the service division within the Power Technique Business Area.

Epiroc AB’s Nomination Committee for the Annual General Meeting 2025

Stockholm, Sweden: According to the Instruction for the Nomination Committee adopted by the Annual General Meeting of Epiroc AB, the Nomination Committee should consist of representatives for the four shareholders, directly registered or ownership grouped, controlling the largest number of votes in Epiroc AB that desire to appoint a member. In addition thereto, the Chairman of the Board of Directors shall be a member.The following persons will form the Nomination Committee for the Annual General Meeting 2025. Petra Hedengran - Investor AB (Chair)Joachim Spetz - Swedbank RoburMikael

Rejlers supports Lahti Energia in constructing a district heat accumulator to enhance energy system flexibility

Lahti Energia is set to enhance its energy efficiency with the construction of a new district heat accumulator at the Kymijärvi power plant. Rejlers has been selected as the engineering partner for the project, providing detailed design services to ensure successful implementation.The project will kick off with planning this autumn, with construction scheduled for 2025. The new district heat accumulator is expected to be operational by 2026, offering improved flexibility in heat production and consumption. "The district heat accumulator provides us with flexibility and efficiency. We can

Notification under Chapter 9, Section 10 of the Finnish Securities Market Act

Neste Corporation, Stock Exchange Release, 3 October 2024 at 9.30 a.m. (EET) Neste Corporation has yesterday received a notification under Chapter 9, Section 10 of the Finnish Securities Market Act (FSMA). The reason for the notification by BlackRock, Inc. is the Group restructure following the acquisition of Global Infrastructure Management LLC (“GIP”) on 1 October 2024. The aggregate holdings including financial instruments according to SMA 9:6a owned by BlackRock, Inc. and the entities referred to above amounts to 5.28% of the total number of shares of Neste Corporation. The share

Lower up-front payments for startups

The boom in biotech has had multiple impacts on early development companies. The lack of funding has forced many to tighten their belts, and several actors have even had to throw in the towel. But how has the new environment affected the prospects for partner agreements?Read the full article at biostock.se : https://www.biostock.se/en/2024/10/lower-up-front-payments-for-startups/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Metso awarded repeat orders for the supply of mill lining solutions to Africa

Metso Corporation’s press release on October 3, 2024, at 9:00 a.m. EESTMetso has been awarded repeat orders for a mining customer’s sites in Africa for the supply of liners for SAG and ball mills. Metso’s scope of supply includes Metallic Liners for the SAG mills, and Metallic and Megaliner ™ composite linings for the Ball mills. Additional services are offered including MillMapper™ liner wear monitoring, Metrics digital monitoring, onsite support, and performance guarantees. By utilizing Metso’s expertise and world-class technology the customer will be able to ramp-up faster to optimal

Total Voting Rights

BLACKROCK INCOME AND GROWTH INVESTMENT TRUST PLC ("the Company")LEI – 5493003YBY59H9EJLJ16 Voting Rights and CapitalIn conformity with the FCA’s Disclosure Guidance and Transparency Rules (the “Rules”) provision 5.6.1, the Company would like to notify the market that as at 03 October 2024 its issued share capital consisted of 19,817,612 Ordinary Shares of 1 pence each (excluding shares held in treasury), carrying one vote per share. As at 03 October 2024, the Company held 10,081,532 Ordinary Shares in treasury (33.72% of the Company’s total issued share capital including treasury

Nordea to present its third-quarter results 2024 on 17 October

The report will be published at approximately 07.30 EET (06.30 CET) on Thursday 17 October 2024.Webcast at 11.00 EET (10.00 CET) Frank Vang-Jensen, President and Group CEO, will present the results followed by a Q&A audio session for investors and analysts with Frank Vang-Jensen, Ian Smith, Group CFO, and Ilkka Ottoila, Head of Investor Relations. To join the live webcast, please use the webcast link.  In the Q&A session, questions to management can be presented by phone. To ask questions, join the teleconference by registering using this link. (

Strong result for Lantmännen in the second four-month period

Lantmännen’s operating income for the second four-month period of 2024, adjusted for items affecting comparability, amounted to 1 116 MSEK – slightly lower than the previous year’s record result of 1 196 MSEK, but the second best four-month result ever.“Lantmännen delivered a strong result both for the second four-month period and for the first eight months of the year. The Agriculture and Food Sectors both showed higher results than the previous year, while the result in the Swecon Business Area was lower. The result in the Energy Sector was considerably lower, due to the ethanol price

Kappahl launches a new collaboration for its brand kay/day with Sanna Jörnvik Déman

Kappahl is launching part two of its brand design collaboration with digital creator Sanna Jörnvik Déman – an autumnal capsule collection that combines stunning materials with timeless design. With lovely autumn evenings in mind, they have created a beautiful and versatile collection in earthy tones that suits all the moments of autumn. The collection will be launched in stores and online on October 16th. - In collaboration with Sanna, we have visualized and created a collection together that lifted kay/day's aesthetic to a new dimension. The fact that Sanna already genuinely

Director/PDMR Shareholding

  3 October 2024 LSE: PDL   Petra Diamonds Limited(Petra, the Company or the Group) Notification and public disclosure of transactions by Director/PDMR Shareholding The Company was notified on 2 October 2024 of the purchase of shares in the Company by José Manuel Vargas, a Non-Executive Director of Petra Diamonds Limited. Mr Vargas has purchased 915,386 ordinary shares of 0.05 pence each (the Shares) in the Company at an average price of 29.40 pence per Share. As a result of these trades, Mr Vargas now holds 22,115,386 Shares representing approximately 11.39%

Karine Nordseth appointed new Managing Director in Nobina Norway

Karine Nordseth has been appointed as the new Managing Director of Nobina Norway and member of Nobina’s Group Management. Karine, who has been serving as interim Managing Director, brings eight years of experience in various strategic roles at Nobina.Throughout her time at Nobina, Karine has held several key leadership roles, including Head of Tender, Marketing Director, and most recently Vice President of Nobina Norway. “After a comprehensive recruitment process, I am pleased to confirm Karine’s transition from interim to permanent Managing Director of Nobina Norway. Her vast experience

Video streaming from ambulance can be life-changing for acute stroke patients

When someone suffers a stroke, time and choice of treatment are critical factors. The outcome largely depends on how quickly the person receives the right care. If the ambulance staff can consult a stroke specialist via video streaming inside the ambulance, before departure, lives could be saved and permanent brain damage prevented. This is shown in a study led by Chalmers University of Technology, in Sweden, which involved all of the key professional groups required when someone suffers an acute stroke. "Using video streaming and consultation in the ambulance, stroke patients

Scape Technologies Introduces a Series of Six Leading-Edge 3D Vision Scanners

At VISION 2024 in Stuttgart, Scape Technologies will present the Ultra and Pro Industrial 3D Stationary Scanner Series, along with a new robot-mounted 3D SCAPE Mini Scanner. Meet us at our booth #10D80 from October 8th to 10th. Be the first to witness a demo of our high-performance, cost-effective 3D vision scanners, as well as our advancements in industrial robotic CNC tending, bin-picking, and object detection. The New SCAPE Industrial 3D Scanner Series: High Performance at Competitive Prices For over twenty years, Scape Technologies has been committed to research and

There are no items matching the current filter
There are no more items matching the current filter
Back to top